Jaguar Health Provides Update Regarding Special Stock Dividend
Key Highlights
- ➤Special stock dividend payable October 15 to eligible shareholders and warrant holders
- ➤Nasdaq sets October 16 ex-dividend date for Jaguar’s Series R preferred stock dividend
- ➤Shares trade with due bills through October 16; sellers transfer dividend rights to buyers
- ➤NDA filing for crofelemer MVID treatment planned for mid-2027
Expert Statements
Lisa Conte, Founder, President, and CEO of Jaguar Health
“Jaguar is issuing the Special Stock Dividend to reward and recognize our passionate and supportive stockholders and provide protection against potential dilution as we continue evaluation of strategic alternatives”
Lisa Conte, Founder, President, and CEO of Jaguar Health
“We remain sharply focused on our ongoing global development program for oral crofelemer as adjunctive therapy to parenteral support for rare intestinal failure diseases, including microvillus inclusion disease (MVID) and short bowel syndrome with intestinal failure (SBS-IF) for crofelemer powder for oral solution.”
SAN FRANCISCO, CA / ACCESS Newswire / October 14, 2026 / Jaguar Health, Inc. (NASDAQ:JAGX) ("Jaguar" or "the Company") today provided an update in connection with the Company's previously announced special stock dividend (the "Special Stock Dividend"), which is payable on October 15, 2026, to holders of Jaguar common stock and certain outstanding warrants as of record on October 13, 2026, to announce that The Nasdaq Stock Market LLC ("Nasdaq") has indicated that the ex-dividend date for the Special Stock Dividend is October 16, 2026 (the "Ex-Dividend Date"). The Special Stock Dividend consists of the Company's Series R Convertible Preferred Stock (the "Preferred Stock").
Nasdaq has advised the Company that its shares of common stock will trade with "due bills" representing an assignment of the right to receive the dividend from the record date of October 13, 2026 until the Ex-Dividend Date (this period of time representing the "Dividend Right Period").
Get started
Create a free account to read the full story.